Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TSBX

Turnstone Biologics Corp

Dec 01 • 04:00PM ET

2.11

Dollar change -0.07
Percentage change -3.21	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-	Insider Own	38.10%	Shs Outstand	23.09M	Perf Week	-17.90%
Market Cap	48.72M	Forward P/E	-	EPS next Y	-	Insider Trans	17.08%	Shs Float	14.29M	Perf Month	-40.56%
Income	-	PEG	-	EPS next Q	-0.76	Inst Own	34.52%	Short Float / Ratio	2.63% / 3.80	Perf Quarter	-82.30%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Interest	0.38M	Perf Half Y	-
Book/sh	4.93	P/B	0.43	EPS next Y	-	ROA	-	Target Price	17.50	Perf Year	-
Cash/sh	4.73	P/C	0.45	EPS next 5Y	-	ROE	-	52W Range	1.62 - 13.20	Perf YTD	-80.82%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-84.02%	Beta	-
Dividend %	-	Quick Ratio	9.08	Sales past 5Y	-27.64%	Gross Margin	-	52W Low	29.85%	ATR	0.40
Employees	-	Current Ratio	9.08	Sales Q/Q	-100.00%	Oper. Margin	-	RSI (14)	39.78	Volatility	10.01% 16.59%
Optionable	No	Debt/Eq	0.03	EPS Q/Q	-1559.14%	Profit Margin	-	Rel Volume	0.38	Prev Close	2.18
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Nov 10 BMO	Payout	-	Avg Volume	98.91K	Price	2.11
Recom	1.00	SMA20	-20.35%	SMA50	-25.11%	SMA200	-65.03%	Volume	37,403	Change	-3.21%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-16-23	Initiated	SVB Securities	Market Perform
Aug-15-23	Initiated	Piper Sandler	Overweight	$20
Aug-15-23	Initiated	BofA Securities	Buy	$18

Nov-27-23 06:00AM	Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-09-23 09:49PM	Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights (GlobeNewswire) -11.94%
Nov-03-23 06:00AM	Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Oct-30-23 06:00AM	Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber (GlobeNewswire) +24.12%
Sep-28-23 06:00AM	Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting (GlobeNewswire) +10.36%
05:57PM	Loading…
Sep-01-23 05:57PM	Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +10.47%
Aug-14-23 08:41PM	Steven Cohen's Q2 2023 13F Filing Update: Top Trades and Portfolio Overview (GuruFocus.com)
Aug-04-23 06:30PM	Apogee Therapeutics, Turnstone Biologics, and More Stocks See Action From Activist Investors (Barrons.com) -5.67%
Jul-27-23 07:01PM	Steven Cohen Acquires Stake in Turnstone Biologics Corp (GuruFocus.com)
05:36PM	FMR LLC Acquires Significant Stake in Turnstone Biologics Corp (GuruFocus.com)
Jul-21-23 02:15AM	Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It is focused on developing new medicines to treat and cure patients with solid tumors. The company was founded in 2015 and is headquartered in La Jolla, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Versant Ventures V, LLC	10% Owner	Jul 25	Buy	12.00	225,000	2,700,000	2,726,322	Jul 27 04:23 PM
Jerel Davis	Director	Jul 25	Buy	12.00	225,000	2,700,000	2,726,322	Jul 27 04:21 PM
Gupta Rishi	Director	Jul 20	Buy	12.00	416,666	4,999,992	3,099,265	Jul 24 04:40 PM
ORBIMED ADVISORS LLC	Director	Jul 20	Buy	12.00	416,666	4,999,992	3,099,265	Jul 24 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TSBX

Turnstone Biologics Corp

Upgrade your FINVIZ experience